Uro Pharmaceuticals, Inc.
Country not established
- Devices
- 1
What Uro Pharmaceuticals, Inc. makes
Uro Pharmaceuticals, Inc. manufactures OB-PH, a pH test paper designed for urinary analysis. This diagnostic tool is used to measure the acidity or alkalinity of urine samples, aiding in the assessment of urinary tract health and potential conditions.
The OB-PH pH test paper is classified as a Class I medical device under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Ob-Ph - Ph Test Paper Ref K850858
510(k) 510(k)
Frequently asked questions
How many devices does Uro Pharmaceuticals, Inc. have in the registry?
The registry currently lists 1 device for Uro Pharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Uro Pharmaceuticals, Inc.'s devices?
Among its 1 most recently registered device, Uro Pharmaceuticals, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Uro Pharmaceuticals, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Uro Pharmaceuticals, Inc.'s devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Uro Pharmaceuticals, Inc. in the registry?
The most recently registered devices listed for Uro Pharmaceuticals, Inc. include OB-PH - PH TEST PAPER.